- Compared to RNA and DNA, metabolites are more diagnostic and easier to detect.
- Compared to circulating tumor cells, metabolites have fewer false negatives.
- Compared to proteins (proteomics), metabolites are more robust and easier to multiplex.
VeraMarker™ CCM (Colon Cancer Monitoring) Test
VeraMarker™ CCS (Colon Cancer Screening) Test
The colon cancer treatment monitoring test will follow.
We are also looking for oncologists interested in helping us advance our portfolio of liver and colon cancer diagnostic tests. We invite you to email Matrix-Bio CEO Dr. Eric Beier for more information.